NO20055205L - 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer - Google Patents
4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorerInfo
- Publication number
- NO20055205L NO20055205L NO20055205A NO20055205A NO20055205L NO 20055205 L NO20055205 L NO 20055205L NO 20055205 A NO20055205 A NO 20055205A NO 20055205 A NO20055205 A NO 20055205A NO 20055205 L NO20055205 L NO 20055205L
- Authority
- NO
- Norway
- Prior art keywords
- tithropyridine
- phenylsulfanyl
- phenyl
- derivatives
- uptake inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Oppfinnelsen tilveiebringer forbindelser representert ved den generelle formel I hvori substituentene er definert i søknaden. Forbindelsene er nyttige i behandlingen av en affektiv lidelse, inklusive depresjon, angstlidelser inklusive generell angstlidelse og panikklidelse og obsessiv-kompulsiv lidelse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300518 | 2003-04-04 | ||
PCT/DK2004/000243 WO2004087662A1 (en) | 2003-04-04 | 2004-04-02 | 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20055205L true NO20055205L (no) | 2005-11-04 |
Family
ID=35432910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055205A NO20055205L (no) | 2003-04-04 | 2005-11-04 | 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer |
Country Status (28)
Country | Link |
---|---|
US (1) | US20070173522A1 (no) |
EP (1) | EP1613594B1 (no) |
JP (1) | JP2006522029A (no) |
KR (1) | KR20060021825A (no) |
CN (1) | CN100384822C (no) |
AR (1) | AR043964A1 (no) |
AT (1) | ATE390413T1 (no) |
AU (1) | AU2004226319A1 (no) |
BR (1) | BRPI0408453A (no) |
CA (1) | CA2521172A1 (no) |
CL (1) | CL2004000730A1 (no) |
CO (1) | CO5700777A2 (no) |
DE (1) | DE602004012724T2 (no) |
DK (1) | DK1613594T3 (no) |
EA (1) | EA009282B1 (no) |
ES (1) | ES2301979T3 (no) |
HK (1) | HK1090051A1 (no) |
HR (1) | HRP20080243T3 (no) |
IS (1) | IS8007A (no) |
MX (1) | MXPA05010678A (no) |
NO (1) | NO20055205L (no) |
NZ (1) | NZ541944A (no) |
PL (1) | PL1613594T3 (no) |
PT (1) | PT1613594E (no) |
SI (1) | SI1613594T1 (no) |
UA (1) | UA81300C2 (no) |
WO (1) | WO2004087662A1 (no) |
ZA (1) | ZA200507182B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004226838B8 (en) | 2003-04-04 | 2009-06-11 | H. Lundbeck A/S | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
JP5173190B2 (ja) | 2004-08-25 | 2013-03-27 | 武田薬品工業株式会社 | 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法 |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
UA98698C2 (en) * | 2008-03-03 | 2012-06-11 | Х. Луннбек А/С | Phenylsulfanylphenyl-piperidines and process for the preparation thereof |
EP2510949A4 (en) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | THERAPEUTICS FOR FIBROMYALGIA |
EP2930171A1 (en) * | 2014-04-07 | 2015-10-14 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate |
CN105294554B (zh) * | 2015-11-18 | 2017-11-07 | 乳源瑶族自治县大众药品贸易有限公司 | 苯基哌嗪衍生物及其使用方法和用途 |
US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803143A (en) * | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
US4018830A (en) * | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
US4055665A (en) * | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
US4066654A (en) * | 1975-04-16 | 1978-01-03 | G. D. Searle & Co. | 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives |
US4056632A (en) * | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
US4241071A (en) * | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
DE2802306A1 (de) * | 1977-01-27 | 1978-08-10 | Hoechst Ag | Azacycloalkane, azacycloalkene und ihre derivate |
US4198419A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenylthiophenylpiperidines |
US4198417A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
GB8912971D0 (en) * | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
US6410736B1 (en) * | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
AU769430B2 (en) * | 1999-10-13 | 2004-01-29 | Pfizer Products Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
AU2152101A (en) * | 1999-12-30 | 2001-07-16 | H. Lundbeck A/S | Substituted phenyl-piperazine derivatives, their preparation and use |
US6436938B1 (en) * | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
US20020107244A1 (en) * | 2001-02-02 | 2002-08-08 | Howard Harry R. | Combination treatment for depression |
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
-
2004
- 2004-02-04 UA UAA200508779A patent/UA81300C2/uk unknown
- 2004-04-02 US US10/551,869 patent/US20070173522A1/en not_active Abandoned
- 2004-04-02 CA CA002521172A patent/CA2521172A1/en not_active Abandoned
- 2004-04-02 DK DK04725299T patent/DK1613594T3/da active
- 2004-04-02 PL PL04725299T patent/PL1613594T3/pl unknown
- 2004-04-02 EP EP04725299A patent/EP1613594B1/en not_active Expired - Lifetime
- 2004-04-02 CN CNB2004800094713A patent/CN100384822C/zh not_active Expired - Fee Related
- 2004-04-02 ZA ZA200507182A patent/ZA200507182B/en unknown
- 2004-04-02 AR ARP040101130A patent/AR043964A1/es not_active Application Discontinuation
- 2004-04-02 NZ NZ541944A patent/NZ541944A/en unknown
- 2004-04-02 MX MXPA05010678A patent/MXPA05010678A/es active IP Right Grant
- 2004-04-02 AT AT04725299T patent/ATE390413T1/de not_active IP Right Cessation
- 2004-04-02 BR BRPI0408453-5A patent/BRPI0408453A/pt not_active IP Right Cessation
- 2004-04-02 SI SI200430727T patent/SI1613594T1/sl unknown
- 2004-04-02 DE DE602004012724T patent/DE602004012724T2/de not_active Expired - Fee Related
- 2004-04-02 EA EA200501579A patent/EA009282B1/ru not_active IP Right Cessation
- 2004-04-02 JP JP2006504348A patent/JP2006522029A/ja active Pending
- 2004-04-02 PT PT04725299T patent/PT1613594E/pt unknown
- 2004-04-02 WO PCT/DK2004/000243 patent/WO2004087662A1/en active IP Right Grant
- 2004-04-02 AU AU2004226319A patent/AU2004226319A1/en not_active Abandoned
- 2004-04-02 ES ES04725299T patent/ES2301979T3/es not_active Expired - Lifetime
- 2004-04-02 KR KR1020057018870A patent/KR20060021825A/ko not_active Application Discontinuation
- 2004-04-02 CL CL200400730A patent/CL2004000730A1/es unknown
-
2005
- 2005-08-29 IS IS8007A patent/IS8007A/is unknown
- 2005-11-02 CO CO05111852A patent/CO5700777A2/es unknown
- 2005-11-04 NO NO20055205A patent/NO20055205L/no unknown
-
2006
- 2006-09-26 HK HK06110721A patent/HK1090051A1/xx not_active IP Right Cessation
-
2008
- 2008-06-03 HR HR20080243T patent/HRP20080243T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CO5700777A2 (es) | 2006-11-30 |
SI1613594T1 (sl) | 2008-08-31 |
PL1613594T3 (pl) | 2008-09-30 |
DE602004012724T2 (de) | 2009-04-09 |
HK1090051A1 (en) | 2006-12-15 |
AR043964A1 (es) | 2005-08-17 |
NZ541944A (en) | 2008-05-30 |
CL2004000730A1 (es) | 2005-02-18 |
PT1613594E (pt) | 2008-07-01 |
IS8007A (is) | 2005-08-29 |
MXPA05010678A (es) | 2005-12-12 |
CN100384822C (zh) | 2008-04-30 |
ZA200507182B (en) | 2006-12-27 |
WO2004087662A1 (en) | 2004-10-14 |
AU2004226319A1 (en) | 2004-10-14 |
US20070173522A1 (en) | 2007-07-26 |
BRPI0408453A (pt) | 2006-04-04 |
EP1613594A1 (en) | 2006-01-11 |
DK1613594T3 (da) | 2008-07-14 |
EP1613594B1 (en) | 2008-03-26 |
EA009282B1 (ru) | 2007-12-28 |
EA200501579A1 (ru) | 2006-04-28 |
ATE390413T1 (de) | 2008-04-15 |
HRP20080243T3 (en) | 2009-04-30 |
CN1777585A (zh) | 2006-05-24 |
CA2521172A1 (en) | 2004-10-14 |
DE602004012724D1 (de) | 2008-05-08 |
KR20060021825A (ko) | 2006-03-08 |
UA81300C2 (en) | 2007-12-25 |
ES2301979T3 (es) | 2008-07-01 |
JP2006522029A (ja) | 2006-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20080478T3 (en) | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors | |
NO20055205L (no) | 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer | |
RS20120158A3 (en) | Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors | |
NO20060402L (no) | 3-amino choman og 2-aminotetralinderivater | |
HRP20080262T3 (en) | 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors | |
NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
NO20055750L (no) | Nye kjemiske forbindelser | |
ATE396970T1 (de) | 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri | |
DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
ATE471320T1 (de) | 4-aminopiperidinderivate als inhibitoren der monoamin-aufnahme | |
UA81469C2 (en) | 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors | |
NO20053562L (no) | Nye aminobenzofenonforbindelser | |
EA200501577A1 (ru) | Производные 4-(2-фенилсульфанилфенил)пиперидина в качестве ингибиторов повторного поглощения серотонина | |
NO20062700L (no) | Morfolinderivater som norepinefrin reopptaksinhibitorer | |
ATE423772T1 (de) | Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin | |
CA2521030A1 (en) | 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors | |
TH83467B (th) | เฮทเทอโรไซเคิลตัวใหม่ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |